Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This is a 3 year,superiority, multicenter, open-label, randomised controlled safety and
efficacy study. The aim of this study is to evaluate the effect of an intravitreal
fluocinolone acetonide (0.59 mg) implant compared to standardized therapy in subjects with
unilateral or bilateral, non-infectious uveitis affecting the posterior segment of the eye.